932 Stock Overview
An investment holding company, engages in the development, manufacture, marketing, sale, trade, and distribution of health and beauty supplements and products in Hong Kong and the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Shunten International (Holdings) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.021 |
| 52 Week High | HK$0.076 |
| 52 Week Low | HK$0.02 |
| Beta | 0.10 |
| 11 Month Change | -40.00% |
| 3 Month Change | -51.16% |
| 1 Year Change | -70.42% |
| 33 Year Change | -85.62% |
| 5 Year Change | -95.38% |
| Change since IPO | -96.99% |
Recent News & Updates
Investors Don't See Light At End Of Shunten International (Holdings) Limited's (HKG:932) Tunnel And Push Stock Down 40%
Aug 07
Is Shunten International (Holdings) (HKG:932) A Risky Investment?
Jul 12Recent updates
Investors Don't See Light At End Of Shunten International (Holdings) Limited's (HKG:932) Tunnel And Push Stock Down 40%
Aug 07Is Shunten International (Holdings) (HKG:932) A Risky Investment?
Jul 12Does Shunten International (Holdings) (HKG:932) Have A Healthy Balance Sheet?
Mar 28Earnings Troubles May Signal Larger Issues for Shunten International (Holdings) (HKG:932) Shareholders
Dec 27Unpleasant Surprises Could Be In Store For Shunten International (Holdings) Limited's (HKG:932) Shares
Sep 13Shunten International (Holdings) (HKG:932) Takes On Some Risk With Its Use Of Debt
Aug 09Is Shunten International (Holdings) (HKG:932) A Risky Investment?
Feb 20Robust Earnings May Not Tell The Whole Story For Shunten International (Holdings) (HKG:932)
Dec 29These 4 Measures Indicate That Shunten International (Holdings) (HKG:932) Is Using Debt Extensively
Jul 12Is Shunten International (Holdings) (HKG:932) A Risky Investment?
Aug 09A Look At The Intrinsic Value Of Shunten International (Holdings) Limited (HKG:932)
Feb 19Here's Why Shunten International (Holdings) (HKG:932) Can Manage Its Debt Responsibly
Jan 15
Trade Alert: The Independent Non-Executive Director Of Shunten International (Holdings) Limited (HKG:932), Kin Yip Tam, Has Sold Some Shares Recently
Dec 11Shareholder Returns
| 932 | HK Personal Products | HK Market | |
|---|---|---|---|
| 7D | -22.2% | 2.1% | -2.0% |
| 1Y | -70.4% | 6.3% | -4.9% |
Return vs Industry: 932 underperformed the Hong Kong Personal Products industry which returned 10.5% over the past year.
Return vs Market: 932 underperformed the Hong Kong Market which returned -5.9% over the past year.
Price Volatility
| 932 volatility | |
|---|---|
| 932 Average Weekly Movement | 14.6% |
| Personal Products Industry Average Movement | 6.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 13.7% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 932's share price has been volatile over the past 3 months.
Volatility Over Time: 932's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 247 | Raymond Yeung | www.shunten.com.hk |
Shunten International (Holdings) Limited, an investment holding company, engages in the development, manufacture, marketing, sale, trade, and distribution of health and beauty supplements and products in Hong Kong and the People’s Republic of China. It operates through Health and Beauty Supplements and Products Business; and Property Investment Business segments. The company offers its products under its proprietary brands, including Royal Medic, Legend, MeltyEnz, CleansingEnz, La Gusto, HARUKA, Mr. 75, and Health Proof.
Shunten International (Holdings) Limited Fundamentals Summary
| 932 fundamental statistics | |
|---|---|
| Market cap | HK$65.27m |
| Earnings (TTM) | HK$571.00k |
| Revenue (TTM) | HK$235.59m |
114.3x
P/E Ratio0.3x
P/S RatioIs 932 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 932 income statement (TTM) | |
|---|---|
| Revenue | HK$235.59m |
| Cost of Revenue | HK$51.37m |
| Gross Profit | HK$184.21m |
| Other Expenses | HK$183.64m |
| Earnings | HK$571.00k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00018 |
| Gross Margin | 78.19% |
| Net Profit Margin | 0.24% |
| Debt/Equity Ratio | 79.8% |
How did 932 perform over the long term?
See historical performance and comparison